Colonics
 
About Me

Colonics resources

Recent Posts
Menu
Calendar
«  October 2014  »
MonTueWedThuFriSatSun
 12345
6789101112
13141516171819
20212223242526
2728293031 

Friends
    Links


    Entry 1 of 3164
    Last Page | Next Page
    3/5/2010 - Apixaban superior to enoxaparin in reducing venous thromboembolism in total knee replacement surgery patients
    Posted in Medical News

    Apixaban, an oral anticoagulant being developed by Bristol-Myers Squibb Company and Pfizer Inc., was statistically superior to 40 mg once daily enoxaparin in reducing the instance of venous thromboembolism in clients undergoing elective total knee stand-in surgery, according to rule to rule to the ADVANCE-2 study results published today in The Lancet. The study results also showed numerically lower rates of major and clinically homogeneity non-major softy in llc.cite this source roget's ii: the new thesaurus treated with apixaban compared with those treated with enoxaparin.

    More: - The rest...

    Share |

    :: Send to a Friend!

    Share and enjoy
    • Digg
    • del.icio.us
    • DZone
    • Netvouz
    • NewsVine
    • Reddit
    • Slashdot
    • StumbleUpon
    • Technorati
    • YahooMyWeb